The application of genomic and molecular data in the treatment of chronic cancer pain.
Many cancer patients will develop complex pain syndromes requiring aggressive, innovative, and comprehensive multimodal pain management strategies. Recently, data from both animal studies and clinical trials have allowed clinical research to focus on creating applicable clinical treatment strategies. This article is a review of genomic and molecular data, which has contributed to creating novel modalities for use in clinical pain management of patients with cancer-induced pain.
SourceJournal of surgical oncology 105:5 2012 Apr 1 pg 494-501
Anti-Inflammatory Agents, Non-Steroidal
Autonomic Nerve Block
Polymorphism, Single Nucleotide
Receptors, Opioid, mu
Translational Medical Research
Pub Type(s)Journal Article